MedPath

A clinical study of intraoperative diagnosis of sentinel lymph node metastasis in head and neck cancer patients using bimolecular methods

Not Applicable
Conditions
Oral cancer
Registration Number
JPRN-UMIN000006508
Lead Sponsor
Aichi Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
21
Inclusion Criteria

Not provided

Exclusion Criteria

1)Previously treated patients 2)Patients judged by the investigator to be unfit to be enrolled into the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We evaluate the concordance rate between the OSNA assay and histopathology for lymph node metastases.
Secondary Outcome Measures
NameTimeMethod
Cutoff values to distinguish macrometastasis, micrometastasis, and nonmetastasis are determined by measuring cytokeratin 19 (CK19) mRNA in histopathologically positive and negative lymph nodes using OSNA.
© Copyright 2025. All Rights Reserved by MedPath